Literature DB >> 15242829

Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats.

Prasanth K Chelikani1, Alvin C Haver, Roger D Reidelberger.   

Abstract

We compared the effects of the two molecular forms of the brain-gut peptide YY (PYY), PYY(1-36) and PYY(3-36), on gastric emptying. Unanesthetized rats received 20-min intravenous infusions of rat PYY(1-36) (0, 1.7, 5, 17, 50, 100, 170 pmol x kg(-1) x min(-1)) and rat PYY(3-36) (0, 0.5, 1.7, 5, 17, 50, 100, 170 pmol x kg(-1) x min(-1)), either alone or combined, and gastric emptying of saline was measured during the last 10 min of infusion. For comparison, human PYY(3-36) was administered at 0, 17, and 50 pmol x kg(-1) x min(-1). Gastric emptying was decreased by 11, 24, 26 and 38% in response to 17, 50, 100, and 170 pmol x kg(-1) x min(-1) of rat PYY(1-36); by 10, 26, 41, 53, and 57% in response to 5, 17, 50, 100, and 170 pmol x kg(-1) x min(-1) of rat PYY(3-36); and by 35 and 53% in response to 17 and 50 pmol x kg(-1) x min(-1) of human PYY(3-36), respectively. Estimated ED50s were 470 and 37 pmol x kg(-1) x min(-1) for rat PYY(1-36) and PYY(3-36), respectively. In general, within an experiment, coadministration of PYY(1-36) and PYY(3-36) inhibited gastric emptying by an amount that was comparable to that produced when either peptide was given alone. We conclude that 1) intravenous infusion of PYY(1-36) and PYY(3-36) each produces a dose-dependent inhibition of gastric emptying in rats, 2) PYY(3-36) is an order of magnitude more potent than PYY(1-36) in inhibiting gastric emptying, 3) human PYY(3-36) and rat PYY(3-36) inhibit gastric emptying similarly, and 4) PYY(1-36) and PYY(3-36) do not appear to interact in an additive or synergistic manner to inhibit gastric emptying. Copyright 2004 American Physiological Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242829     DOI: 10.1152/ajpregu.00376.2004

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  26 in total

Review 1.  Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin.

Authors:  Laura A Berner; Tiffany A Brown; Jason M Lavender; Emily Lopez; Christina E Wierenga; Walter H Kaye
Journal:  Mol Cell Endocrinol       Date:  2018-11-02       Impact factor: 4.102

Review 2.  New targets to treat obesity and the metabolic syndrome.

Authors:  Kathleen A Martin; Mitra V Mani; Arya Mani
Journal:  Eur J Pharmacol       Date:  2015-05-19       Impact factor: 4.432

3.  Abdominal surgery inhibits circulating acyl ghrelin and ghrelin-O-acyltransferase levels in rats: role of the somatostatin receptor subtype 2.

Authors:  Andreas Stengel; Miriam Goebel-Stengel; Lixin Wang; Almaas Shaikh; Nils W G Lambrecht; Jean Rivier; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-02       Impact factor: 4.052

Review 4.  Changes in neurohormonal gut peptides following bariatric surgery.

Authors:  C N Ochner; C Gibson; M Shanik; V Goel; A Geliebter
Journal:  Int J Obes (Lond)       Date:  2010-07-13       Impact factor: 5.095

5.  Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY.

Authors:  S Unniappan; C H S McIntosh; H-U Demuth; U Heiser; R Wolf; T J Kieffer
Journal:  Diabetologia       Date:  2006-06-27       Impact factor: 10.122

6.  PYY(1-36) is the major form of PYY in rat distal small intestine: quantification using high-resolution mass spectrometry.

Authors:  David A Keire; Julian P Whitelegge; Puneet Souda; Kym F Faull; Sara Bassilian; Roger D Reidelberger; Alvin C Haver; Joseph R Reeve
Journal:  Regul Pept       Date:  2010-07-06

Review 7.  Control of energy homeostasis by amylin.

Authors:  Thomas A Lutz
Journal:  Cell Mol Life Sci       Date:  2011-12-23       Impact factor: 9.261

8.  Ghrelin and peptide YY increase with weight loss during a 12-month intervention to reduce dietary energy density in obese women.

Authors:  Brenna R Hill; Barbara J Rolls; Liane S Roe; Mary Jane De Souza; Nancy I Williams
Journal:  Peptides       Date:  2013-09-25       Impact factor: 3.750

9.  The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study.

Authors:  Adrian Vella; Gerlies Bock; Paula D Giesler; Duane B Burton; Denise B Serra; Monica Ligueros Saylan; Carolyn F Deacon; James E Foley; Robert A Rizza; Michael Camilleri
Journal:  Clin Endocrinol (Oxf)       Date:  2008-03-10       Impact factor: 3.478

10.  Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice.

Authors:  Lixin Wang; Guillaume Gourcerol; Pu-Qing Yuan; S Vincent Wu; Mulugeta Million; Muriel Larauche; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-05       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.